Cargando…
Towards advanced bioprocess optimization: A multiscale modelling approach
Mammalian cells produce up to 80 % of the commercially available therapeutic proteins, with Chinese Hamster Ovary (CHO) cells being the primary production host. Manufacturing involves a train of reactors, the last of which is typically run in fed-batch mode, where cells grow and produce the required...
Autores principales: | Monteiro, Mariana, Fadda, Sarah, Kontoravdi, Cleo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371800/ https://www.ncbi.nlm.nih.gov/pubmed/37520284 http://dx.doi.org/10.1016/j.csbj.2023.07.003 |
Ejemplares similares
-
Understanding the impact of different bioprocess conditions on monoclonal antibody glycosylation in CHO cell cultures through experimental and computational analyses
por: Sou, Si N, et al.
Publicado: (2015) -
Sustainable Design Approach for Modeling Bioprocesses from Laboratory toward Commercialization: Optimizing Chitosan Production
por: Meramo, Samir, et al.
Publicado: (2021) -
Population balance modelling captures host cell protein dynamics in CHO cell cultures
por: Alhuthali, Sakhr, et al.
Publicado: (2022) -
A theoretical estimate for nucleotide sugar demand towards Chinese Hamster Ovary cellular glycosylation
por: del Val, Ioscani Jimenez, et al.
Publicado: (2016) -
Modelling of amorphous cellulose depolymerisation by cellulases, parametric studies and optimisation
por: Niu, Hongxing, et al.
Publicado: (2016)